Advertisement

Cancer and Metastasis Reviews

, Volume 1, Issue 1, pp 5–16 | Cite as

‘Seed and soil’ revisited: mechanisms of site-specific metastasis

  • Ian R. Hart
Article

Summary

Clinical studies have shown that malignant tumors frequently show definite metastatic patterns. This tendency for neoplasms of a particular histologic type to metastasize to a specific organ is also a characteristic of experimental animal tumor systems. Mechanical entrapment, arrest determined by specific recognition between neoplastic cells and capillaries and organ-determined modulation of tumor growth have all been suggested as mechanisms that regulate this specificity. Experimental evidence for the role that each of these mechanisms plays in the regulation of metastatic patterns of transplantable rodent tumors is discussed in this review.

Keywords

metastasis site-specific metastasis tumor cell adhesion organ-specific tumors 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Paget S: The distribution of secondary growths in cancer of the breast. Lancet 1: 571–573, 1889.Google Scholar
  2. 2.
    Ewing J: A treatise on tumors, 3rd edn. W.B. Saunders, Philadelphia, 1928.Google Scholar
  3. 3.
    Sugarbaker EV: Patterns of metastasis in human malignancies. In: Marchalonis JJ, Hanna MG, Fidler IJ (eds) Cancer biology reviews, Vol 2. Marcel Dekker, New York, 1980.Google Scholar
  4. 4.
    Lindberg R: Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 29: 1446–1449, 1972.Google Scholar
  5. 5.
    Weiss L, Haydock K, Pickren JW, Lane WW: Organ vascularity and metastatic frequency. Am J Pathol 101: 101–114, 1980.Google Scholar
  6. 6.
    Fidler IJ, Gersten DM, Hart IR: The biology of cancer invasion and metastasis. Adv Cancer Res 28: 149–250, 1978.Google Scholar
  7. 7.
    Fidler IJ: General considerations for studies of experimental cancer metastasis. In: Busch H (ed) Methods in cancer research, Vol XV. Academic Press, New York, 1978.Google Scholar
  8. 8.
    Wexler H: Accurate identification of experimental pulmonary metastases. J Natl Cancer Inst 36: 641–645, 1966.Google Scholar
  9. 9.
    Fidler IJ: Selection of successive tumour lines for metastasis. Nature (New Biol) 242: 148–149, 1973.Google Scholar
  10. 10.
    Becker FF: Patterns of spontaneous metastasis of transplantable hepatocellular carcinomas. Cancer Res 38: 163–167, 1978.Google Scholar
  11. 11.
    Van de Velde CJH, Van Putten LM, Zwaveling A: A new metastasizing mammary carcinoma model in mice: Model characteristics and applications. Eur J Cancer 13: 555–565, 1977.Google Scholar
  12. 12.
    Cloudman AM: Organophilic tendencies of two transplantable tumors of the mouse. Cancer Res 7: 585–591, 1947.Google Scholar
  13. 13.
    Pilgrim HI: The kinetics of the organ-specific metastasis of a transplantable reticuloendothelial tumor. Cancer Res 29: 1200–1205, 1969.Google Scholar
  14. 14.
    Parks RC: Organ-specific metastasis of a transplantable reticulum cell sarcoma. J Natl Cancer Inst 52: 971–973, 1974.Google Scholar
  15. 15.
    Greene HSN, Harvey EK: Relationship between the dissemination of tumor cells and the distribution of metastases. Cancer Res 24: 799–811, 1964.Google Scholar
  16. 16.
    Kerbel RS: Implications of immunological heterogeneity of tumours. Nature 280: 358–360, 1979.Google Scholar
  17. 17.
    Hart IR, Fidler IJ: The implications of tumor heterogeneity for studies on the biology and therapy of cancer metastasis. Biochim Biophys Acta 651: 37–50, 1981.Google Scholar
  18. 18.
    Fidler IJ, Kripke ML: Metastasis results from preexisting variant cells within a malignant tumor. Science 197: 893–895, 1977.Google Scholar
  19. 19.
    Kripke ML, Gruys E, Fidler IJ: Metastatic heterogeneity of cells from an ultraviolet light-induced murine sarcoma of recent origin. Cancer Res 36: 1962–1968, 1978.Google Scholar
  20. 20.
    Fidler IJ, Hart IR: The origin of metastatic heterogeneity in tumors. Eur J Cancer 17: 487–494, 1981.Google Scholar
  21. 21.
    Poste G, Fidler IJ: The pathogenesis of cancer metastasis. Nature 283: 139–143, 1979.Google Scholar
  22. 22.
    Brunson KW, Beattie G, Nicolson GL: Selection and altered properties of brain-colonizing metastatic melanoma. Nature 272: 543–545, 1978.Google Scholar
  23. 23.
    Tao T, Matter A, Vogel K, Burger MM: Liver-colonizing melanoma cells selected from B16 melanoma. Int J Cancer 23: 854–857, 1979.Google Scholar
  24. 24.
    Shearman PJ, Longenecker BM: Selection for virulence and organ-specific metastasis of herpes virus-transformed lymphoma cells. Int J Cancer 25: 363–369, 1980.Google Scholar
  25. 25.
    Brunson KW, Nicolson GL: Selection of malignant melanoma variant cell lines for ovary colonization. J Supramol Struct 11: 517–525, 1979.Google Scholar
  26. 26.
    Raz A, Hart IR: Murine melanoma: A model for intracranial metastasis. Br J Cancer 42: 331–341, 1980.Google Scholar
  27. 27.
    Nicolson GL, Brunson KW, Fidler IJ: Specificity of arrest, survival, growth of selected metastatic variant cell lines. Cancer Res 38: 4105–4111, 1978.Google Scholar
  28. 28.
    Proctor JW: Rat sarcoma model supports both ‘soil seed’ and ‘mechanical’ theories of metastatic spread. Br J Cancer 34: 651–654, 1976.Google Scholar
  29. 29.
    Griffiths JD, Salsbury AJ: The fate of circulating Walker 256 tumour cells injected intravenously into rats. Br J Cancer 17: 546–557, 1963.Google Scholar
  30. 30.
    Fidler IJ, Nicolson GL: Organ selectivity for implantation, survival and growth of B16 melanoma variant tumor lines. J Natl Cancer Inst 57: 1190–1202, 1976.Google Scholar
  31. 31.
    Fidler IJ, Gersten DM, Riggs CW: Relationship of host immune status to tumor cell arrest, distribution and survival in experimental metastasis. Cancer 40: 46–55, 1977.Google Scholar
  32. 32.
    Fisher B, Fisher ER: The organ distribution of disseminated 51Cr-labeled tumor cells. Cancer Res 27: 412–420, 1967.Google Scholar
  33. 33.
    Fisher B, Fisher ER: Barrier function of lymph node to tumor cells and erythrocytes. Cancer 20: 1907–1919, 1979.Google Scholar
  34. 34.
    Zeidman I, Buss JM: Transpulmonary passage of tumor cell emboli. Cancer Res 12: 731–738, 1952.Google Scholar
  35. 35.
    Sato H, Suzuki M: Deformability and viability of tumor cells by transcapillary passage with reference to organ affinity of metastasis in cancer. In: Weiss L (ed), Fundamental aspects of metastasis. North-Holland, Amsterdam, pp 311–317, 1976.Google Scholar
  36. 36.
    Zeidman I: The fate of circulating tumor cells. 1. Passage of cells through capillaries. Cancer Res 21: 38–39, 1961.Google Scholar
  37. 37.
    Wood S: Experimental studies of the intravascular dissemination of ascitic V2 carcinoma cells in the rabbit, with special reference to fibrinogen and fibrinolytic agents. Bull Schweiz Akad Med Wiss 20: 92–121, 1964.Google Scholar
  38. 38.
    Weiss L: Cancer cell traffic from the lungs to the liver. An example of metastatic inefficiency. Int J Cancer 25: 385–392, 1980.Google Scholar
  39. 39.
    Nicolson GL: Experimental tumor metastasis: Characteristics and organ specificity. BioScience 28: 441–447, 1978.Google Scholar
  40. 40.
    Roser B: The distribution of intravenously injected Kupffer cells in the mouse. J Reticuloendothel Soc 5: 455–471, 1968.Google Scholar
  41. 41.
    Gillette RW: Variation in the homing properties of 51Cr-labeled Thy antigen-positive lymphoma. Cell Immunol 51: 23–31, 1980.Google Scholar
  42. 42.
    Gillette RW, Fox A: Changes with age in the homing properties and mitogen responses of lymphocytes from normal and leukemia-prone mice. Cell Immunol 51: 32–41, 1980.Google Scholar
  43. 43.
    Nicolson GL, Winkelhake JL: Organ specificity of blood-borne tumour metastasis determined by cell adhesion. Nature 255: 230–232, 1975.Google Scholar
  44. 44.
    Schirrmacher V, Cheinsong-Popov R, Arnheiter H: Hepatocyte-tumor cell interaction in vitro. 1. Conditions for rosette formation and inhibition by anti-H-2-antibody. J Exp Med 151: 984–989, 1980.Google Scholar
  45. 45.
    Kahan B: Ovarian localization by embryonal teratocarcinoma cells derived from female germ cells. Somatic Cell Genet 5: 763–780, 1979.Google Scholar
  46. 46.
    Shearman PJ, Gallatin WM, Longenecker BM: Detection of a cell-surface antigen correlated with organ-specific metastasis. Nature 286: 267–269, 1980.Google Scholar
  47. 47.
    Nicolson GL: Cell surface proteins and glycoproteins of metastatic murine melanomas and sarcomas. In: Ruddon R (ed) Biological markers of neoplasia: basic and applied aspects. Elsevier North-Holland, Amsterdam, pp 227–239, 1978.Google Scholar
  48. 48.
    Sinha BK, Goldenberg GJ: The effect of trypsin and neuraminidase on the circulation and organ distribution of tumor cells. Cancer 34: 1956–1961, 1974.Google Scholar
  49. 49.
    Weiss L, Fisher B, Fisher ER: Observations on the effect of neuraminidase on the distribution of intravenously injected Walker tumor cells in rats. Cancer 34: 680–683, 1975.Google Scholar
  50. 50.
    Hagmar B, Ryd W: Tumor cell locomotion: A factor in metastasis formation. Influence of cytochalasin B on a tumor dissemination pattern. Int J Cancer 19: 576–580, 1977.Google Scholar
  51. 51.
    Hart IR, Raz A, Fidler IJ: Effect of cytoskeleton-disrupting agents on the metastatic behavior of melanoma cells. J Natl Cancer Inst 64: 891–900, 1980.Google Scholar
  52. 52.
    Poste G, Nicolson GL: Modification of the arrest of metastatic tumor cells in the microcirculation after treatment with plasma membrane vesicles from highly metastatic cells. Proc Natl Acad Sci USA 77: 399–403, 1980.Google Scholar
  53. 53.
    Fidler IJ, Nicolson GL: Fate of recirculating B16 melanoma metastatic variant cells in parabiotic syngeneic recipiens. J Natl Cancer Inst 58: 1867–1872, 1977.Google Scholar
  54. 54.
    Talmadge JE, Key M, Hart IR: Characterization of a murine ovarian reticulum cell sarcoma of histiocytic origin. Cancer Res 41: 1271–1280, 1981.Google Scholar
  55. 55.
    Hart IR, Talmadge JE, Fidler IJ: Metastatic behavior of a murine reticulum cell sarcoma exhibiting organ-specific growth. Cancer Res 41: 1281–1287, 1981.Google Scholar
  56. 56.
    Giavazzi R, Alessandri G, Spreafico F, Garattini S, Mantovani A: Metastasizing capacity of tumour cells from spontaneous metastases of transplanted murine tumours. Br J Cancer 42: 462–472, 1980.Google Scholar
  57. 57.
    Nicolson GL, Custead SE: Tumor metastasis is not due to adaptation of cells to a new organ environment. Science 215: 176–178, 1982.Google Scholar
  58. 58.
    Weissmann G, Bloomgarden D, Kaplan R, Cohen C, Hoffstein S, Collins T, Gotlieb A, Nagle D: A general method for the introduction of enzymes by means of immunoglobulin-coated liposomes into lysosomes of deficient cells. Proc Natl Acad Sci USA 72: 88–92, 1975.Google Scholar
  59. 59.
    Gregoriadis G, Buckland RA: Enzyme-containing liposomes alleviate a model for storage disease. Nature 244: 170–172, 1973.Google Scholar
  60. 60.
    Folkman J, Handenschild CC, Zetter BR: Long-term culture of capillary endothelial cells. Proc Natl Acad Sci USA 76: 5217–5221, 1979.Google Scholar
  61. 61.
    Kramer RH, Nicolson GL: Interactions of tumor cells with vascular endothelial cell monolayers: A model for metastatic invasion. Proc Natl Acad Sci USA 76: 5704–5708, 1979.Google Scholar
  62. 62.
    Kramer RH, Gonzalez R, Nicolson GL: Metastatic tumor cells adhere preferentially to the extracellular matrix underlying vascular endothelial cells. Int J Cancer 26: 639–645, 1980.Google Scholar
  63. 63.
    Murray JC, Liotta L, Rennard SI, Martin GR: Adhesion characteristics of murine metastatic and nonmetastatic tumor cells in vitro. Cancer Res 40: 347–351, 1980.Google Scholar
  64. 64.
    Nicolson GL, Irimura T, Gonzalez R, Ruoslahti E: The role of fibronectrin in adhesion of metastatic melanoma cells to endothelial cells and their basal lamina. Exp Cell Res 135: 461–465, 1981.Google Scholar
  65. 65.
    Terranova VP, Foltz C, Murray JC, Martin GR: Laminin as an attachment factor for metastatic cells (abstract). Proc Am Assoc Cancer Res 22: 55, 1981.Google Scholar
  66. 66.
    Poste G, Doll J, Hart IR, Fidler IJ: In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res 40: 1636–1644, 1980.Google Scholar
  67. 67.
    Warren BA: Environment of the blood-borne tumor embolus adherent to vessel wall. J Med 4: 150–177, 1973.Google Scholar
  68. 68.
    Kleinman HK, Klebe RJ, Martin GR: Role of collagenous matrices in the adhesion and growth of cells. J Cell Biol 88: 473–485, 1981.Google Scholar
  69. 69.
    Vlodavsky I, Gospodarowicz D, Respective roles of laminin and fibronectin in adhesion of human carcinoma and sarcoma cells. Nature 289: 304–307, 1981.Google Scholar
  70. 70.
    Terranova VP, Rohrbach DH, Martin GR: Role of laminin in the attachment of PAM 212 (epithelial cells) to basement membrane collagen. Cell 22: 719–726, 1980.Google Scholar
  71. 71.
    Giavazzi R, Liotta L, Hart IR: Laminin inhibits the adhesion of a murine tumor of macrophage origin. Exp Cell Res (in press).Google Scholar
  72. 72.
    Albrechsten R, Nielsen M, Wever U, Engvall E, Ruoslahti E: Basement membrane changes in breast cancer detected by immunohistochemical staining for laminin. Cancer Res 41: 5076–5081, 1981.Google Scholar
  73. 73.
    Neri A, Ruoslahti E, Nicolson GL: Distribution of fibronectin on cloned cell lines of a rat mammary adenocarcinoma growing in vitro and in vivo at primary and metastatic sites. Cancer Res 41: 5082–5095, 1981.Google Scholar
  74. 74.
    Kinsey DL: An experimenal study of preferential metastasis. Cancer 13: 674–676, 1960.Google Scholar
  75. 75.
    Sugarbaker EV, Cohen AM, Ketcham AS: Do metastases metastasize? Ann Surg 174: 161–166, 1971.Google Scholar
  76. 76.
    Hart IR, Fidler IJ: Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res 40: 2281–2287, 1980.Google Scholar
  77. 77.
    Fisher B, Fisher ER, Feduska N: Trauma and the localization of tumor cells. Cancer 20: 23–30, 1967.Google Scholar
  78. 78.
    Agostino D, Cliffton EE: Organ localization and the effect of trauma on the fate of circulating cancer cells. Cancer Res 25: 1728–1732, 1965.Google Scholar
  79. 79.
    Bellamy D, Hinsull SM: Influence of lodgement site on the proliferation of metastases of Walker 256 carcinoma in the rat. Br J Cancer 37: 81–85, 1978.Google Scholar
  80. 80.
    Klein K, Coetzee ML, Madhav R, Ove P: Inhibition of tritiated thymidine incorporation in cultured cells by rat kidney extract. J Natl Cancer Inst 62: 1557–1564, 1979.Google Scholar
  81. 81.
    Todaro GJ, Fryling C, DeLarco JE: Transforming growth factors produced by certain human tumor cells: Polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci USA 77: 5258–5262, 1980.Google Scholar
  82. 82.
    Gospodarowicz D, Greenburg G, Bialecki H, Zetter BR: Factors involved in the modulation of cell proliferation in vivo and in vitro: The role of fibroblast and epidermal growth factors in the proliferative response of mammalian cells. In Vitro 14: 85–118, 1978.Google Scholar
  83. 83.
    Reif A: Evidence for organ specificity of defenses against tumors. In: Waters H (ed) The handbook of cancer immunology, Vol 1. Gauland STPM, New York, pp 174–240, 1978.Google Scholar
  84. 84.
    Folkman J: Tumor angiogenesis. Adv Cancer Res 19: 331–358, 1974.Google Scholar

Copyright information

© Martinus Nijhoff Publishers 1982

Authors and Affiliations

  • Ian R. Hart
    • 1
  1. 1.Cancer Metastasis and Treatment LaboratoryNCI-Frederick Cancer Research FacilityFederickU.S.A.

Personalised recommendations